The Fourth General Assembly meeting of Remadyl Consortium has just concluded. The partners met online for two technical working sessions (May 25-26, 2021) to assess the project progresses. The project has now reached a focal point in the actuation of its workplan. In the previous months, all partners had been occupied carrying out their assigned tasks.
During this two-days meeting they discussed significant results and progresses achieved under the different WorkPackages. For instance, some trials had been upscaled and other tasks successfully completed. As proof of the good work carried out together, the overall feedback on the reviewed period was positive.
The Coordinator provided useful recommendations and action points to orientate the work until the next planned General Assembly in M30.